How one plasmid, one week, and a single orthogonal replication system are rewriting the rules of protein evolution — and what it means for enzyme manufacturing.

T7-ORACLE (T7 Orthogonal Replication for Accelerated Continuous Laboratory Evolution) is a directed-evolution system developed by Peter Schultz's team at Scripps Research, published in Science on August 7, 2025. Using a single plasmid inside living E. coli cells, it drives continuous, targeted hypermutation of a chosen gene — achieving up to a 5,000-fold increase in protein activity within one week, without specialized equipment or repetitive manual screening.

Background

No complex instruments. No repetitive manipulation. Just one plasmid—and your target gene can undergo continuous hypermutation inside living cells, enhancing protein activity by thousands of times within a week!

It may sound like a synthetic biologist’s dream, but it has now become reality. On August 7, 2025, Peter Schultz’s team at the Scripps Research Institute published a groundbreaking study in Science, unveiling a system called T7-ORACLE, an orthogonal replication system that enables continuous, rapid, and targeted gene hypermutation in E. coli. This represents a revolutionary breakthrough in protein-directed evolution.

Directed protein evolution has generated next-generation T7 RNA polymerase variants with 50% higher yield and 90% reduced dsRNA contamination. These engineered enzymes enable cost-effective mRNA manufacturing for vaccines and therapeutics.

Bottlenecks in Traditional Evolution Technologies

Directed evolution is a key strategy for optimizing protein function, yet traditional approaches such as error-prone PCR or DNA shuffling have significant limitations: they rely on multiple rounds of in vitro mutation–transformation–screening cycles, which are labor-intensive and time-consuming, and they often fail to achieve deep evolutionary changes.

Although recent in vivo evolution technologies (like PACE) have improved efficiency, they still face issues such as non-targeted mutations, host genome instability, and the need for specialized equipment.

Inspired by bacteriophage T7, the Schultz team developed a fully orthogonal replication system composed of multiple components: T7 replicative proteins, including RNA polymerase, DNA polymerase, helicase–primase fusion protein, and single-stranded DNA-binding protein.

Mechanism:

The system works by expressing T7 RNA polymerase, DNA polymerase, helicase–primase, and single-stranded binding protein, which specifically recognize and replicate circular target plasmids carrying the T7 replication origin.

To promote replication, a catalytically defective T7 lysozyme is fused to the T7 RNA polymerase. The inhibitory effect of T7 lysozyme prevents full transcription, generating short RNA primers that initiate replication by T7 DNA polymerase.

By introducing engineered T7 DNA polymerase variants (Δ28 deletion and key mutations N520M, P560V, and V443K), the fidelity of replication is drastically reduced.

Figure 1. Schematic diagram of the directed evolution workflow

T7-ORACLE: A Precise “Genetic Editing Engine”

The Schultz team designed the T7-ORACLE system as a fully orthogonal replication mechanism inspired by bacteriophage T7.

It consists of several key components: T7 RNA polymerase, DNA polymerase, helicase–primase fusion protein, and single-stranded binding protein.

The system specifically targets plasmids carrying the T7 replication origin (φOR) for replication.

Figure 2. Life cycle of T7 bacteriophage

Figure 3. Schematic diagram of system design principle

To maximize mutational efficiency, the engineered DNA polymerase exhibits reduced proofreading activity and base selectivity, resulting in controlled hypermutation.

Most importantly, this system targets only the plasmid-borne genes without disturbing the host genome, allowing E. coli cells to maintain normal growth while achieving extremely high mutation rates in the target sequence.

How Is a Million-Fold Increase in Mutation Rate Achieved?

The researchers used rational design and directed evolution to iteratively optimize T7 DNA polymerase:

Removing proofreading activity: 

An exonuclease-deficient mutant (Δ28) raised the mutation rate 25-fold.

Reducing base-pairing fidelity: 

Key mutations N520M, P560V, and V443K further lowered replication accuracy.

Figure 4. Engineered T7 DNA polymerases involved in this study

The resulting five-mutation polymerase achieved a mutation rate of 1.7×10⁻⁵ per base per generation, nearly 100,000 times higher than the host genome mutation rate, while maintaining high transformation efficiency (2.4×10¹⁰ cfu/μg).

Stability tests of the optimized system included:

Fluctuation analysis, 

 confirming excellent orthogonality (genomic mutation rate 4.4×10⁻¹⁰ spb);

Sequencing of mutation spectra, 

showing unbiased substitution patterns (balanced transition/transversion rates);

Serial passage experiments, 

confirming plasmid stability and negligible metabolic burden for plasmids up to 13 kb

Figure 5. Stability testing of the optimized system

Application: Hyperactive β-Lactamase Evolved in Just One Week

To validate the system’s practicality, the team applied it to evolve TEM-1 β-lactamase.

In less than one week, mutants exhibiting 5,000-fold higher resistance to several clinically important antibiotics (aztreonam, cefotaxime, ceftazidime, and cefepime) were obtained.

Remarkably, the mutations that emerged (such as G238S, R164H, and E104K) were identical to those observed in clinical antibiotic-resistant strains, proving that the system accurately mimics natural evolutionary processes.

Figure 6. Continuous evolution of β-lactamase

Breaking Local Optima: From a Single Starting Point to Global Library Evolution

One of T7-ORACLE’s major advantages is its compatibility with pre-constructed mutation libraries.

The researchers compared different evolutionary starting points:

From the wild-type sequence 

– the evolution pathway was highly convergent (single-directional evolution).

From single-point saturation mutants 

– multiple unidirectional trajectories emerged.

From a full saturation library 

– multiple multidirectional trajectories were observed, enabling exploration of the global fitness landscape and identification of global optima.

Figure 7. Exploring broader fitness landscapes from multiple starting points toward whole-library evolution

Technological Prospects and Significance

Key advantages of this work include:

Development of a hypermutation system combining strong target specificity, safety, and long mutational reach 

— maintaining host genome stability while enabling evolution of any target protein length.

Accelerating protein functional evolution and overcoming local fitness peaks 

— by integrating pre-diversified mutation libraries to shift from directed evolution to global adaptive landscape exploration.

However, questions remain regarding whether the mutation distribution along target genes is fully uniform, and whether bias toward promoter-proximal regions occurs.

Note:

This study was published in Science on August 7, 2025, under the title:
“An orthogonal T7 replisome for continuous hypermutation and accelerated evolution in E. coli.”

Original article link:

https://www.science.org/doi/10.1126/science.adp9583

Product Recommendation

GMP-Grade T7 RNA Polymerase

GMP-Grade T7 RNA Polymerase — Product Specifications

Features

• High Fidelity: 

no significant difference in fidelity compared to wild-type T7 RNA by Sanger sequencing

• Strict QC panel: 

multi-dimensional quality control of enzymes; CV≤15%

• 30+ standard mutants available: 

High mRNA Integrity Mutant: Cat No.HBP000330 /Low dsRNA Mutant13: Cat No.HBP000340/Thermostable Mutant: Cat No.HBP000350

• GMP-Grade, Non-Animal Origin (AOF), DMF Record: MF036856

From the Lab Bench to Your Reaction Tube

T7-ORACLE-style directed evolution isn't a lab curiosity — it's the same evolutionary logic behind the polymerases and reverse transcriptases that ship out of Hzymes every week. When we push a Taq variant through iterative rounds of in vivo mutagenesis and selection, we're not optimizing for a single trait in isolation — we're screening for the combination that matters in your workflow: sharper hot-start specificity, higher processivity with fewer primer-dimers, and consistent lot-to-lot performance at scale.

That's the practical translation of "directed evolution": fewer failed runs, tighter Ct values across plates, and a polymerase that behaves the same way in batch 40 as it did in batch 4. What changes from generation to generation isn't just the molecule — it's how fast we can get there. Platforms like T7-ORACLE compress years of trial-and-error screening into weeks, which is exactly what lets Hzymes keep pace every time a new application — multiplex qPCR, LAMP, or mRNA IVT enzymes — calls for a slightly different performance profile.

Orderings